Phibro Animal Health Corp (NASDAQ:PAHC)’s share price hit a new 52-week low during trading on Thursday . The company traded as low as $32.02 and last traded at $32.78, with a volume of 3129 shares. The stock had previously closed at $32.99.
A number of brokerages have commented on PAHC. BidaskClub lowered shares of Phibro Animal Health from a “sell” rating to a “strong sell” rating in a report on Wednesday, November 28th. Zacks Investment Research upgraded shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a report on Friday, November 16th. ValuEngine lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Monday, November 12th. Finally, Morgan Stanley boosted their price objective on shares of Phibro Animal Health from $36.00 to $46.00 and gave the stock an “underweight” rating in a report on Wednesday, August 29th. Three investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $43.50.
The company has a current ratio of 3.26, a quick ratio of 1.82 and a debt-to-equity ratio of 1.62. The firm has a market capitalization of $1.33 billion, a P/E ratio of 18.97, a price-to-earnings-growth ratio of 2.82 and a beta of 0.77.
Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Tuesday, November 6th. The company reported $0.39 EPS for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.03). Phibro Animal Health had a return on equity of 38.91% and a net margin of 7.89%. The firm had revenue of $200.20 million during the quarter, compared to analyst estimates of $203.99 million. During the same quarter in the prior year, the firm earned $0.38 EPS. The business’s quarterly revenue was up 3.5% compared to the same quarter last year. As a group, research analysts expect that Phibro Animal Health Corp will post 1.72 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Wednesday, November 28th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Tuesday, November 27th. This represents a $0.48 dividend on an annualized basis and a yield of 1.45%. This is a positive change from Phibro Animal Health’s previous quarterly dividend of $0.10. Phibro Animal Health’s payout ratio is currently 27.59%.
In other news, VP Daniel M. Bendheim sold 2,500 shares of the company’s stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $44.30, for a total value of $110,750.00. Following the sale, the vice president now owns 2,500 shares in the company, valued at approximately $110,750. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Dean J. Warras sold 10,000 shares of the company’s stock in a transaction dated Thursday, November 1st. The shares were sold at an average price of $42.84, for a total transaction of $428,400.00. Following the completion of the sale, the insider now owns 10,000 shares in the company, valued at approximately $428,400. The disclosure for this sale can be found here. Insiders sold a total of 13,020 shares of company stock worth $562,571 in the last quarter. 50.29% of the stock is currently owned by company insiders.
Several institutional investors have recently modified their holdings of PAHC. Royal Bank of Canada raised its stake in shares of Phibro Animal Health by 2,104.6% in the 1st quarter. Royal Bank of Canada now owns 3,814 shares of the company’s stock valued at $151,000 after purchasing an additional 3,641 shares in the last quarter. Principal Financial Group Inc. raised its stake in shares of Phibro Animal Health by 2.6% in the 1st quarter. Principal Financial Group Inc. now owns 160,503 shares of the company’s stock valued at $6,372,000 after purchasing an additional 4,116 shares in the last quarter. Piedmont Investment Advisors LLC acquired a new stake in shares of Phibro Animal Health in the 2nd quarter valued at about $213,000. Dupont Capital Management Corp acquired a new stake in shares of Phibro Animal Health in the 2nd quarter valued at about $745,000. Finally, Alps Advisors Inc. acquired a new stake in shares of Phibro Animal Health in the 2nd quarter valued at about $431,000. Institutional investors and hedge funds own 49.63% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2018/12/07/phibro-animal-health-pahc-sets-new-1-year-low-at-32-02.html.
Phibro Animal Health Company Profile (NASDAQ:PAHC)
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Further Reading: How does inflation affect different investments?
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.